Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Bunzl Plc Reiterates 2025 Adj. Operating Profit Guidance (AFX) +++ BUNZL Aktie -3,02%

ARCADIA BIOSCIENCES Aktie

>ARCADIA BIO Performance
1 Woche: 0%
1 Monat: 0%
3 Monate: 0%
6 Monate: 0%
1 Jahr: -33,6%
laufendes Jahr: -36,9%
>ARCADIA BIOSCIENCES Aktie
Name:  ARCADIA BIOSCIENCES
Land:  USA
Sektor:  Chemie
ISIN/ Wkn:  US0390143032 / A3D7B0
Symbol/ Ticker:  17D (Frankfurt) / RKDA (NASDAQ)
Kürzel:  FRA:17D, ETR:17D, 17D:GR, NASDAQ:RKDA
Index:  -
Webseite:  https://arcadiabio.com/
Profil:  Arcadia Biosciences Inc. is a biotechnology compan..
>Volltext..
Marktkapitalisierung:  4.26 Mio. EUR
Unternehmenswert:  -0.76 Mio. EUR
Umsatz:  4.41 Mio. EUR
EBITDA:  -7.3 Mio. EUR
Nettogewinn:  -4.32 Mio. EUR
Gewinn je Aktie:  -3.16 EUR
Schulden:  -
Liquide Mittel:  0.95 Mio. EUR
Operativer Cashflow:  -5.18 Mio. EUR
Bargeldquote:  2.58
Umsatzwachstum:  -1.8%
Gewinnwachstum:  13.04%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  ARCADIA BIOSCIENCES, ARCADIA BIO
Letzte Datenerhebung:  17.12.25
>ARCADIA BIO Kennzahlen
Aktien/ Unternehmen:
Aktien: 1.37 Mio. St.
Frei handelbar: 99.18%
Rückkaufquote: -0.12%
Mitarbeiter: 9
Umsatz/Mitarb.: 0.48 Mio. EUR
Analysten:
Analystenrating: Neutral
Kursziel: -
Bewertung:
KGV: -
KGV lG: -
KUV: 0.98
KBV: 0.91
PEG-Ratio: -
EV/EBITDA: -
Rentabilität:
Bruttomarge: 37.81%
Gewinnmarge: -97.43%
Operative Marge: -172.01%
Managementeffizenz:
Gesamtkaprendite: -42.31%
Eigenkaprendite: -64.08%
>ARCADIA BIO Peer Group

Es sind 95 Aktien bekannt.
 
10.11.25 - 08:54
Arcadia Biosciences GAAP EPS of $0.63 beats by $1.29, revenue of $1.3M misses by $0.1M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
07.11.25 - 22:09
Arcadia Biosciences (RKDA) Announces Third Quarter 2025 Financial Results and Business Highlights (GlobeNewswire EN)
 
-- Zola® year-to-date revenues increase 26% year over year ---- Arcadia gross profit margins exceed 30% for 11th straight quarter ---- Arcadia cash balance declines by only $257K to $1.1M -- DALLAS, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today released its financial and business results for the third quarter of 2025....
15.08.25 - 00:12
Arcadia Biosciences Sales Up 11 Percent (Fool)
 
Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...
14.08.25 - 22:54
Arcadia Biosciences GAAP EPS of -$3.26, revenue of $1.45M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
14.08.25 - 22:33
Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2025 Financial Results and Business Highlights (GlobeNewswire EN)
 
-- Arcadia revenues increase 11% year over year driven by 24% growth in Zola® -- -- Arcadia receives 2.7 million shares of stock in ABVE --...
08.05.25 - 14:24
Arcadia Biosciences reports Q1 results (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
08.05.25 - 14:06
Arcadia Biosciences (RKDA) Announces First Quarter 2025 Financial Results and Business Highlights (GlobeNewswire EN)
 
Arcadia Biosciences' revenues increased 22% year over year in Q1 2025, driven by 90% growth in Zola® coconut water....
07.05.25 - 18:54
Arcadia Biosciences Q1 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
29.04.25 - 14:06
Arcadia Biosciences (RKDA) Announces Date of First Quarter 2025 Financial Results and Business Highlights Conference Call (GlobeNewswire EN)
 
Arcadia Biosciences, Inc.® (Nasdaq: RKDA) will release its financial and business results for the first quarter of 2025 on May 8, 2025 at 2:00 p.m. ET....
22.04.25 - 22:36
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RKDA, CKPT, QTRX on Behalf of Shareholders (PR Newswire)
 
NEW YORK, April 22, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Arcadia Biosciences, Inc. (NASDAQ:......
21.03.25 - 00:42
Arcadia Biosciences outlines 2025 growth potential for Zola after 46% sales increase in 2024 (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
20.03.25 - 21:18
Arcadia Biosciences GAAP EPS of -$2.98, revenue of $1.22M beats by $0.07M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
20.03.25 - 21:09
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2024 Financial Results and Business Highlights (Business Wire)
 
-- Year-over-year revenues grew 56% in Q4 and 13% for full year -- -- Zola® year-over-year revenues increased 124% in Q4 and 46% for full year -- -- Company plans business combination with Roosevelt Resources, Inc. -- DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the fourth quarter and full year of 2024. “We are extremely pleased with the progress we made in 2024, particularly in the second half of the year following the sale of our GoodWheat™ assets,” said T.J. Schaefer, president and CEO. “Our focus on Zola® coconut water led to 80 percent revenue growth for the brand in the back half of the year and drove total Arcadia revenue growth above 30 percent. At the same time revenue growth was accelerating, we maintained tight cost controls, resulting in the lowest use of cash from operations since Arcadia went public a decade ago. “In the fo...
19.03.25 - 22:39
Arcadia Biosciences Q4 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
06.03.25 - 14:03
Arcadia Biosciences (RKDA) Announces Date of Fourth Quarter 2024 Financial Results and Business Highlights Conference Call (Business Wire)
 
DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the fourth quarter and full year of 2024 after market close on March 20, 2025. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss fourth-quarter and year-end results and key strategic achievements. Interested participants can join the conference call using the following options: An audio-only webcast of the conference call will be available, with a link posted in the Investors section of Arcadia's website. To join the live call, please register here, and a dial-in number and unique PIN will be provided. Following completion of the call, a recorded replay will be available in the Investors Section of the company's website. About Arcadia Biosciences, Inc. Since 2002, Arcadia Biosciences (Nasdaq: RKDA) has been innovating high-va...
24.02.25 - 18:24
XFRA : Diverse Instrumente: Aussetzung/Suspension (XETRA)
 
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL CASTOR MARITIME INC. 1C1 MHY1146L2082 BAW/UFN AFFIMED N.V. EO-,10 A28A NL0015001ZQ0 BAW/UFN AETHLON MEDIC.NEW DL-,001 EJU0 US00808Y4061 BAW/UFN AMERICAN R.H. NEW DL-,001 B0Y US02919L5057 BAW/UFN ARCADIA BIOSC.NEW.DL-,001 17D US0390143032 BAW/UFN ENERGY FOCUS INC. DL-0001 FI4A US29268T5083 BAW/UFN KARTOON STUD. NEW DL-,001 4XV0 US37229T5092 BAW/UFN HOUSTON AMERN ENE.DL-,001 8H6H US44183U2096 BAW/UFN ZOOMCAR HLDGS NEW DL-,001 EO30 US45784G2003 BAW/UFN MARIN SOFTWARE DL -,001 2MA US56804T3041 BAW/UFN NOVA LIFESTYLE DL-,01 15N US66979P3001 BAW/UFN PLUS THERAPEUTICS ...
24.02.25 - 18:18
XFRA : INSTRUMENT_SUSPENSION - US0390143032 (XETRA)
 
Instrument ID [15050792] (17D - US0390143032) suspended...
06.02.25 - 02:01
Insiderhandel: Chief Executive Officer kauft Aktien von Arcadia Biosciences im Wert von 1743 USD (Insiderkauf)
 
Schaefer, Thomas J. - Vorstand - Tag der Transaktion: 2025-02-03...
09.12.24 - 18:03
Arcadia Biosciences to Merge With Roosevelt, Shares Surge 105% (Zacks)
 
RKDA inks deal with Roosevelt to become a new entity, Roosevelt Resources, with Roosevelt as the majority shareholder....
18.11.24 - 20:18
Arcadia Biosciences′ Q3 Earnings Miss Estimates, Sales Increase Y/Y (Zacks)
 
RKDA witnesses a solid 55% improvement in Zola sales in Q3. The company continues to invest to grow the Zola brand....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Der Mensch ward zum Tun und nicht zum Vernünfteln erschaffen. Aber eben deswegen, weil er nicht dazu erschaffen ward, hängt er diesem mehr als jenem nach. - Gotthold Ephraim Lessing
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!